Valuation: GSK plc

Market Cap 75.89B 155,065B 102B 90.65B 83.75B 142B 9,637B 144B 1,008B 399B 5,049B 381B 373B 15,918B P/E 2026 *
14x
P/E 2027 * 12.1x
Enterprise Value 97B 198,185B 130B 116B 107B 181B 12,317B 184B 1,288B 510B 6,453B 487B 477B 20,345B EV / Sales 2026 *
2.86x
EV / Sales 2027 * 2.65x
Free-Float
92.75%
Yield 2026 *
3.67%
Yield 2027 * 3.94%
1 day-0.67%
1 week+4.34%
Current month+7.34%
1 month+4.45%
3 months+1.85%
6 months+2.90%
Current year+11.82%
1 week 20,010
Extreme 20010
21,120
1 month 18,440
Extreme 18440
21,120
Current year 17,020
Extreme 17020
22,760
1 year 15,450
Extreme 15450
22,760
3 years 7,173
Extreme 7173
22,760
5 years 2,171.5
Extreme 2171.5
22,760
10 years 543.12
Extreme 543.125
22,760
Manager TitleAgeSince
Chief Executive Officer 52 2025-12-31
Director of Finance/CFO 64 2023-04-30
Compliance Officer - 2018-07-31
Director TitleAgeSince
Director/Board Member 52 2026-05-05
Director/Board Member 64 2017-12-31
Chairman 67 2019-08-31
Change 5-day change 1-year change 3-year change Capi.($)
-0.67%+4.34% - - 102B
-2.54%+1.31%+54.27%+114.96% 1,135B
-1.42%+3.23%+38.56%+74.44% 636B
+0.16%+0.08%+25.29%+95.23% 505B
-0.31%+3.09%+44.14%+64.80% 378B
-1.34%-0.47%+66.04%+41.00% 358B
-0.68%+2.65%+22.98%+50.39% 295B
-1.20%+3.04%+2.33%+22.86% 266B
-1.79%+1.57%+50.56%+59.08% 237B
-0.73%-0.10%+29.02%+99.67% 193B
Average -1.05%+2.17%+37.02%+69.16% 444.93B
Weighted average by Cap. -1.33%+2.66%+41.02%+79.75%

Financials

2026 *2027 *
Net sales 33.9B 69,256B 45.34B 40.49B 37.4B 63.41B 4,304B 64.46B 450B 178B 2,255B 170B 167B 7,109B 35.51B 72,553B 47.5B 42.42B 39.18B 66.43B 4,509B 67.53B 472B 187B 2,362B 178B 174B 7,448B
Net income 5.49B 11,212B 7.34B 6.55B 6.06B 10.27B 697B 10.44B 72.87B 28.85B 365B 27.55B 26.96B 1,151B 6.23B 12,719B 8.33B 7.44B 6.87B 11.65B 790B 11.84B 82.66B 32.73B 414B 31.25B 30.58B 1,306B
Net Debt 21.1B 43,120B 28.23B 25.21B 23.29B 39.48B 2,680B 40.14B 280B 111B 1,404B 106B 104B 4,427B 18.29B 37,379B 24.47B 21.85B 20.19B 34.23B 2,323B 34.79B 243B 96.18B 1,217B 91.84B 89.88B 3,837B
Projected Income Statement - Annual - GSK plc
Logo GSK plc
GSK plc is the world's No. 2 pharmaceutical group. Net sales break down by family of products as follows: - pharmaceutical products (41.3%): intended mainly for HIV infection (57% of net sales), immune system disorders and respiratory diseases (28.3%), and cancer (14.7%); - OTC and parapharmaceutical medicine (30.7%); - vaccines (28%). Net sales are distributed geographically as follows: the United Kingdom (2.1%), Europe (21%), the United States (51.6%), and other (25.3%).
Employees
66,841
Date Price Change Volume
26-10-23 ARS 20,900.00 -0.67% 88
26-10-22 ARS 21,040.00 +2.94% 5,463
26-10-21 ARS 20,440.00 -1.30% 335
26-10-20 ARS 20,710.00 +3.34% 425
26-10-19 ARS 20,040.00 +0.05% 873
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - GSK plc
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
18.94GBP
Average target price
21.75GBP
Spread / Average Target
+14.83%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - GSK plc